Category Health & IP

Global Public-Private Partnerships Against IP Crimes: How Interpol Avoided The Failures Of WCO And WHO

Christopher J. Paun writes: Public-private partnerships (PPPs) are often used as a way of increasing public policy options by tapping into private sector resources. This occurs also in the field of intellectual property. There are several examples of Global PPPs against IP crimes - some more successful than others. Some prominent failures received a lot of attention when PPP activities were stopped following controversy about global IP policy.

US Supreme Court May Invalidate Gene Patents, But Create Little Change

Prior to 15 April, most experts had expected the United States Supreme Court to rule in Association for Molecular Pathology v. Myriad Genetics that genes cannot be patented. The oral argument on that date strengthened this consensus opinion, but also suggested that the court would issue a narrow decision which would allow many types of gene-related patents. Should this happen, the US would move significantly closer to other countries’ rules for gene patents, but the US would continue to have problems limiting patent rights in order to protect the public interest.

Curbing Vaccine Costs Key To Extending Global Immunisation Reach

As the World Health Organization kicks off a week devoted to the promotion of vaccines, newly published research has identified challenges, such as weak supply systems and information gaps, that need to be addressed to scale-up global vaccine coverage. But some observers say that more attention should be paid to the soaring costs of vaccines, starting with a mechanism to track prices.

Health Research Colloquium Calls On Countries To Invest More In R&D

During the recent Council on Health Research for Development (COHRED) Colloquium 2013, participants highlighted the value of research and development in supporting public health and the importance of building self-reliance for countries through government investment, according to organisers. Some of the themes discussed during the event will be included in a report on public health policy, which will be published in The Lancet later this year.

North American Universities Seen Failing To Promote Socially Responsible Licensing

A student group is holding top research universities in the US and Canada accountable for how much they are – or are not – contributing to global public health. According to a recently released report by Universities Allied for Essential Medicines, a non-profit organisation, most institutions are falling short when it comes to investing in neglected diseases and promoting access to medicines.